跳至主要内容
临床试验/NCT00397683
NCT00397683终止2 期

Proprietary Information - Exploratory (Non-Confirmatory) Trial

Merck Sharp & Dohme LLC20 个研究点 分布在 5 个国家目标入组 2 人开始时间: 2006年10月最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
终止
入组人数
2
试验地点
20
主要终点
Proprietary Information - Exploratory (Non-Confirmatory) Trial

研究概览

简要总结

The purpose of this study is to test MK0822 on disease activity in patients with osteoarthritis in the knee. Disease modifying activity of MK0822 will be assessed by measurements of knee cartilage using Magnetic Resonance Imaging (MRI) of the knee.

This is an early phase trial and some specific protocol information is proprietary and not publicly available at this time. (Full information is available to trial participants).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with symptomatic knee osteoarthritis for at least 6 months based on clinical and radiographic criteria
  • Patients should be in general good health and must have a certain level of knee pain or be taking pain medicines on most days
  • Specific radiographic (X-ray) and MRI features must also be satisfied

排除标准

  • Non-osteoarthritic causes of knee pain
  • Ineligibility to undergo MRI of the knee due to patient tolerability or safety reasons
  • Previous septic arthritis, tibial osteotomy or knee replacement in both knees
  • Acute injury of knee ligaments or meniscus in past 2 years
  • Knee arthroscopy in past 12 months
  • Anticipated arthroscopy or surgery in next 18 months
  • Use of intra-articular injections of hyaluronan (e.g. Hyalgan (TM), Synvisc (TM), Orthovisc (TM)) in past 6 months, or injections of glucocorticoids (e.g. Kenalog (TM), Aristospan (TM), Depo-Medrol (TM)) in past 3 months or anticipated knee injections during the study
  • Glucosamine or chondroitin sulfate are allowable if they are at a stable dose for past 3 months and will continue at that dose during the study
  • Other exclusion criteria apply-Please ask the study doctor for details

结局指标

主要结局

Proprietary Information - Exploratory (Non-Confirmatory) Trial

次要结局

  • Proprietary Information - Exploratory (Non-Confirmatory) Trial

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (20)

Loading locations...

相似试验

A 52-Week Study to Assess the Effects of MK0822 on... | 临床试验